Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Neurodegenerative Disease industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
UCB
Merck Serono
Boehringer Ingelheim
Pfizer
GlaxoSmithKline
TEVA
Biogen Idec
Sanofi
Novartis
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
NMDA
SSRIs
Dopamine Inhibitors
Application:
Parkinson’s Disease
Huntington Disease
Amyotrophic Lateral Sclerosis
Alzheimer’s Disease
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Neurodegenerative Disease Industry Overview
-
1.1.1 Neurodegenerative Disease Market Scope and Market Segments
-
1.1.2 Neurodegenerative Disease Industry Characteristics
-
1.1.3 Global and China Neurodegenerative Disease Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Neurodegenerative Disease Production Value and Growth Rate (2017-2028)
-
1.2 Global Neurodegenerative Disease Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 NMDA
-
1.2.2 SSRIs
-
1.2.3 Dopamine Inhibitors
-
1.3 Global Neurodegenerative Disease Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Parkinson’s Disease
-
1.3.2 Huntington Disease
-
1.3.3 Amyotrophic Lateral Sclerosis
-
1.3.4 Alzheimer’s Disease
-
1.4 Market Analysis by Region
-
1.4.1 North America Neurodegenerative Disease Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Neurodegenerative Disease Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Neurodegenerative Disease Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Neurodegenerative Disease Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Neurodegenerative Disease Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Neurodegenerative Disease Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Neurodegenerative Disease Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Neurodegenerative Disease Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Neurodegenerative Disease Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Neurodegenerative Disease Industry Porter's Five Forces Model Analysis
-
2.2.3 Neurodegenerative Disease Industry PEST Analysis
-
2.3 Neurodegenerative Disease Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Neurodegenerative Disease Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Neurodegenerative Disease Industry
Chapter 3 Global and China Neurodegenerative Disease Market, by Manufacturer
-
3.1 Global and China Neurodegenerative Disease Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Neurodegenerative Disease Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Neurodegenerative Disease Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Neurodegenerative Disease Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Neurodegenerative Disease Market Top 3 Players
Chapter 4 Global and China Neurodegenerative Disease Market, by Type (2017-2028)
-
4.1 Neurodegenerative Disease Market Trend, by Type
-
4.2 Global Neurodegenerative Disease Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Neurodegenerative Disease Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Neurodegenerative Disease Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Neurodegenerative Disease Price Trend, by Type (2017-2028)
-
4.3 China Neurodegenerative Disease Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Neurodegenerative Disease Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Neurodegenerative Disease Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Neurodegenerative Disease Price Trend, by Type (2017-2028)
Chapter 5 Global and China Neurodegenerative Disease Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Neurodegenerative Disease Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Neurodegenerative Disease Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Neurodegenerative Disease Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Neurodegenerative Disease Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Neurodegenerative Disease Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Neurodegenerative Disease Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Neurodegenerative Disease Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Neurodegenerative Disease Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Neurodegenerative Disease Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Neurodegenerative Disease Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Neurodegenerative Disease Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Neurodegenerative Disease Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Neurodegenerative Disease Market Analysis
-
7.1 North America Neurodegenerative Disease Market, by Type
-
7.2 North America Neurodegenerative Disease Market, by Application
-
7.3 North America Neurodegenerative Disease Market Analysis and Forecast, by Country
-
7.3.1 United States Neurodegenerative Disease Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Neurodegenerative Disease Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Neurodegenerative Disease Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Neurodegenerative Disease Market Analysis
-
8.1 Europe Neurodegenerative Disease Market, by Type
-
8.2 Europe Neurodegenerative Disease Market, by Application
-
8.3 Europe Neurodegenerative Disease Market Analysis and Forecast, by Country
-
8.3.1 Germany Neurodegenerative Disease Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Neurodegenerative Disease Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Neurodegenerative Disease Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Neurodegenerative Disease Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Neurodegenerative Disease Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Neurodegenerative Disease Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Neurodegenerative Disease Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Neurodegenerative Disease Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Neurodegenerative Disease Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Neurodegenerative Disease Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Neurodegenerative Disease Market Analysis
-
9.1 APAC Neurodegenerative Disease Market, by Type
-
9.2 APAC Neurodegenerative Disease Market, by Application
-
9.3 APAC Neurodegenerative Disease Market Analysis and Forecast, by Country
-
9.3.1 China Neurodegenerative Disease Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Neurodegenerative Disease Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Neurodegenerative Disease Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Neurodegenerative Disease Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Neurodegenerative Disease Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Neurodegenerative Disease Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Neurodegenerative Disease Market Analysis
-
10.1 Latin America, Middle East and Africa Neurodegenerative Disease Market, by Type
-
10.2 Latin America, Middle East and Africa Neurodegenerative Disease Market, by Application
-
10.3 Latin America, Middle East and Africa Neurodegenerative Disease Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Neurodegenerative Disease Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Neurodegenerative Disease Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Neurodegenerative Disease Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Neurodegenerative Disease Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Neurodegenerative Disease Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Neurodegenerative Disease Company Profiles
-
11.1 UCB
-
11.1.1 UCB Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 UCB Neurodegenerative Disease Product Profiles, Application and Specification
-
11.1.3 UCB Neurodegenerative Disease Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Merck Serono
-
11.2.1 Merck Serono Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Merck Serono Neurodegenerative Disease Product Profiles, Application and Specification
-
11.2.3 Merck Serono Neurodegenerative Disease Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Boehringer Ingelheim
-
11.3.1 Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Boehringer Ingelheim Neurodegenerative Disease Product Profiles, Application and Specification
-
11.3.3 Boehringer Ingelheim Neurodegenerative Disease Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Pfizer
-
11.4.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Pfizer Neurodegenerative Disease Product Profiles, Application and Specification
-
11.4.3 Pfizer Neurodegenerative Disease Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 GlaxoSmithKline
-
11.5.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 GlaxoSmithKline Neurodegenerative Disease Product Profiles, Application and Specification
-
11.5.3 GlaxoSmithKline Neurodegenerative Disease Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 TEVA
-
11.6.1 TEVA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 TEVA Neurodegenerative Disease Product Profiles, Application and Specification
-
11.6.3 TEVA Neurodegenerative Disease Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Biogen Idec
-
11.7.1 Biogen Idec Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Biogen Idec Neurodegenerative Disease Product Profiles, Application and Specification
-
11.7.3 Biogen Idec Neurodegenerative Disease Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Sanofi
-
11.8.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Sanofi Neurodegenerative Disease Product Profiles, Application and Specification
-
11.8.3 Sanofi Neurodegenerative Disease Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Novartis
-
11.9.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Novartis Neurodegenerative Disease Product Profiles, Application and Specification
-
11.9.3 Novartis Neurodegenerative Disease Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Neurodegenerative Disease Industry Investment Prospect and Risk Assessment
-
12.1 Neurodegenerative Disease Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Neurodegenerative Disease Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Neurodegenerative Disease Sales Volume and Growth Rate (2017-2028)
-
Figure China Neurodegenerative Disease Sales Volume and Growth Rate (2017-2028)
-
Figure Global Neurodegenerative Disease Production Value and Growth Rate (2017-2028)
-
Figure China Neurodegenerative Disease Production Value and Growth Rate (2017-2028)
-
Figure Global Neurodegenerative Disease Market Size and Growth Rate of NMDA (2017-2028)
-
Figure Global Neurodegenerative Disease Market Size and Growth Rate of SSRIs (2017-2028)
-
Figure Global Neurodegenerative Disease Market Size and Growth Rate of Dopamine Inhibitors (2017-2028)
-
Figure Global Neurodegenerative Disease Market Size and Growth Rate of Parkinson’s Disease (2017-2028)
-
Figure Global Neurodegenerative Disease Market Size and Growth Rate of Huntington Disease (2017-2028)
-
Figure Global Neurodegenerative Disease Market Size and Growth Rate of Amyotrophic Lateral Sclerosis (2017-2028)
-
Figure Global Neurodegenerative Disease Market Size and Growth Rate of Alzheimer’s Disease (2017-2028)
-
Figure North America Neurodegenerative Disease Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Neurodegenerative Disease Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Neurodegenerative Disease Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Neurodegenerative Disease Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Neurodegenerative Disease Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Neurodegenerative Disease Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Neurodegenerative Disease Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Neurodegenerative Disease Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Neurodegenerative Disease Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Neurodegenerative Disease Market Share, by Manufacturer in 2021
-
Figure Global and China Neurodegenerative Disease Market Share, by Manufacturer in 2022
-
Table Global Neurodegenerative Disease Sales Volume, by Type (2017-2028)
-
Table Global Neurodegenerative Disease Sales Volume Share, by Type (2017-2028)
-
Figure Global Neurodegenerative Disease Sales Volume Share, by Type (2017-2028)
-
Table Global Neurodegenerative Disease Sales Value, by Type (2017-2028)
-
Table Global Neurodegenerative Disease Sales Value Share, by Type (2017-2028)
-
Figure Global Neurodegenerative Disease Price Trend, by Type (2017-2028)
-
Table China Neurodegenerative Disease Sales Volume, by Type (2017-2028)
-
Table China Neurodegenerative Disease Sales Volume Share, by Type (2017-2028)
-
Figure China Neurodegenerative Disease Sales Volume Share, by Type (2017-2028)
-
Table China Neurodegenerative Disease Sales Value, by Type (2017-2028)
-
Table China Neurodegenerative Disease Sales Value Share, by Type (2017-2028)
-
Figure China Neurodegenerative Disease Price Trend, by Type (2017-2028)
-
Table Global Neurodegenerative Disease Sales Volume, by Application (2017-2028)
-
Table Global Neurodegenerative Disease Sales Volume Share, by Application (2017-2028)
-
Figure Global Neurodegenerative Disease Sales Volume Share, by Application (2017-2028)
-
Table Global Neurodegenerative Disease Sales Value, by Application (2017-2028)
-
Table Global Neurodegenerative Disease Sales Value Share, by Application (2017-2028)
-
Figure Global Neurodegenerative Disease Sales Value Share, by Application (2017-2028)
-
Table China Neurodegenerative Disease Sales Volume, by Application (2017-2028)
-
Table China Neurodegenerative Disease Sales Volume Share, by Application (2017-2028)
-
Figure China Neurodegenerative Disease Sales Volume Share, by Application (2017-2028)
-
Table China Neurodegenerative Disease Sales Value, by Application (2017-2028)
-
Table China Neurodegenerative Disease Sales Value Share, by Application (2017-2028)
-
Figure China Neurodegenerative Disease Sales Value Share, by Application (2017-2028)
-
Figure China Neurodegenerative Disease Production, Import, Consumption and Export (2017-2022)
-
Figure North America Neurodegenerative Disease Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Neurodegenerative Disease Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Neurodegenerative Disease Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Neurodegenerative Disease Production, Import, Consumption and Export (2017-2022)
-
Table North America Neurodegenerative Disease Sales Volume, by Type (2017-2028)
-
Table North America Neurodegenerative Disease Sales Volume Share, by Type (2017-2028)
-
Figure North America Neurodegenerative Disease Sales Volume Share, by Type (2017-2028)
-
Table North America Neurodegenerative Disease Sales Volume, by Application (2017-2028)
-
Table North America Neurodegenerative Disease Sales Volume Share, by Application (2017-2028)
-
Figure North America Neurodegenerative Disease Sales Volume Share, by Application (2017-2028)
-
Figure United States Neurodegenerative Disease Sales Volume and Growth Rate (2017-2028)
-
Figure United States Neurodegenerative Disease Sales Value and Growth Rate (2017-2028)
-
Figure Canada Neurodegenerative Disease Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Neurodegenerative Disease Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Neurodegenerative Disease Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Neurodegenerative Disease Sales Value and Growth Rate (2017-2028)
-
Table Europe Neurodegenerative Disease Sales Volume, by Type (2017-2028)
-
Table Europe Neurodegenerative Disease Sales Volume Share, by Type (2017-2028)
-
Figure Europe Neurodegenerative Disease Sales Volume Share, by Type (2017-2028)
-
Table Europe Neurodegenerative Disease Sales Volume, by Application (2017-2028)
-
Table Europe Neurodegenerative Disease Sales Volume Share, by Application (2017-2028)
-
Figure Europe Neurodegenerative Disease Sales Volume Share, by Application (2017-2028)
-
Figure Germany Neurodegenerative Disease Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Neurodegenerative Disease Sales Value and Growth Rate (2017-2028)
-
Figure UK Neurodegenerative Disease Sales Volume and Growth Rate (2017-2028)
-
Figure UK Neurodegenerative Disease Sales Value and Growth Rate (2017-2028)
-
Figure France Neurodegenerative Disease Sales Volume and Growth Rate (2017-2028)
-
Figure France Neurodegenerative Disease Sales Value and Growth Rate (2017-2028)
-
Figure Italy Neurodegenerative Disease Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Neurodegenerative Disease Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Neurodegenerative Disease Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Neurodegenerative Disease Sales Value and Growth Rate (2017-2028)
-
Figure Spain Neurodegenerative Disease Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Neurodegenerative Disease Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Neurodegenerative Disease Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Neurodegenerative Disease Sales Value and Growth Rate (2017-2028)
-
Figure Poland Neurodegenerative Disease Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Neurodegenerative Disease Sales Value and Growth Rate (2017-2028)
-
Figure Russia Neurodegenerative Disease Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Neurodegenerative Disease Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Neurodegenerative Disease Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Neurodegenerative Disease Sales Value and Growth Rate (2017-2028)
-
Table APAC Neurodegenerative Disease Sales Volume, by Type (2017-2028)
-
Table APAC Neurodegenerative Disease Sales Volume Share, by Type (2017-2028)
-
Figure APAC Neurodegenerative Disease Sales Volume Share, by Type (2017-2028)
-
Table APAC Neurodegenerative Disease Sales Volume, by Application (2017-2028)
-
Table APAC Neurodegenerative Disease Sales Volume Share, by Application (2017-2028)
-
Figure APAC Neurodegenerative Disease Sales Volume Share, by Application (2017-2028)
-
Figure China Neurodegenerative Disease Sales Volume and Growth Rate (2017-2028)
-
Figure China Neurodegenerative Disease Sales Value and Growth Rate (2017-2028)
-
Figure Japan Neurodegenerative Disease Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Neurodegenerative Disease Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Neurodegenerative Disease Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Neurodegenerative Disease Sales Value and Growth Rate (2017-2028)
-
Figure India Neurodegenerative Disease Sales Volume and Growth Rate (2017-2028)
-
Figure India Neurodegenerative Disease Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Neurodegenerative Disease Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Neurodegenerative Disease Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Neurodegenerative Disease Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Neurodegenerative Disease Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Neurodegenerative Disease Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Neurodegenerative Disease Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Neurodegenerative Disease Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Neurodegenerative Disease Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Neurodegenerative Disease Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Neurodegenerative Disease Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Neurodegenerative Disease Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Neurodegenerative Disease Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Neurodegenerative Disease Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Neurodegenerative Disease Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Neurodegenerative Disease Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Neurodegenerative Disease Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Neurodegenerative Disease Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Neurodegenerative Disease Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Neurodegenerative Disease Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Neurodegenerative Disease Sales Value and Growth Rate (2017-2028)
-
Table UCB Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table UCB Product Profiles, Application and Specification
-
Table UCB Neurodegenerative Disease Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Merck Serono Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Merck Serono Product Profiles, Application and Specification
-
Table Merck Serono Neurodegenerative Disease Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Boehringer Ingelheim Product Profiles, Application and Specification
-
Table Boehringer Ingelheim Neurodegenerative Disease Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Pfizer Product Profiles, Application and Specification
-
Table Pfizer Neurodegenerative Disease Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table GlaxoSmithKline Product Profiles, Application and Specification
-
Table GlaxoSmithKline Neurodegenerative Disease Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table TEVA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table TEVA Product Profiles, Application and Specification
-
Table TEVA Neurodegenerative Disease Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Biogen Idec Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Biogen Idec Product Profiles, Application and Specification
-
Table Biogen Idec Neurodegenerative Disease Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sanofi Product Profiles, Application and Specification
-
Table Sanofi Neurodegenerative Disease Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis Product Profiles, Application and Specification
-
Table Novartis Neurodegenerative Disease Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
